Abstract:During cancer progression, cells lose their original tissue contacts, move through the extracellular matrix (ECM), enter into the lymphatic and/or blood system, extravasate, and ultimately form new tumors. Therefore, tumor cells inevitably experience alterations in cell-cell and cell-ECM adhesion and the transformation activities of tumor cells are highly influenced by cell adhesion via adhesion receptors such as cadherins, integrins, cell surface proteoglycans, and tetraspanins. These adhesion receptors, together with extracellular ligands in the tumor microenvironment, couple the extracellular environment to intracellular signals, thereby enhancing cancer cell migration, invasion, proliferation, and survival. Therefore, knowledge of the role of cell adhesion in cancer is key to understanding the development of cancer, and such knowledge could potentially form the basis for effective approaches to cancer treatment. Therefore, in this issue, we have invited several authors to address such issues. The special issue will be composed of three parts. A set of four papers discuss regulatory mechanisms in the light of interesting issues that have arisen recently, such as the role of cell-ECM interactions in genetic mutations in tumors, as well as the important roles of lipid rafts, turnover of focal adhesions, and anoikis resistance in cancer cell adhesion and migration. All of these characteristics have been shown to be important in cancer cell adhesion, and recent findings provide potential mechanisms of tumor cell interactions and metastatic activities. Another set of five papers of this special issue address the molecular level regulatory role of cell adhesion molecules such as integrins and the immunoglobulin super family and adhesion-related regulatory molecules such as plakoglobin, HIC-5, and prostaglandins. All of these molecules have received considerable attention in cell adhesion research and have distinct role(s) in different aspects of cancer progression, but all are important regulators of human carcinogenesis through their capacity to regulate cancer cell adhesion. However, because their roles in cancer cell adhesion and metastasis are still under investigation, this special issue addresses their functional significance, particularly in the context of cancer cell adhesion. A set of two papers address the possibility of suppressing tumors by regulating cell adhesion status using ECM-derived functional peptides or a physiological regulator such as heparin. Research in this area will improve the understanding of cancer progression and may provide the basis for a new strategy for treating cancer. Eok-Soo Oh Motoharu Seiki Martin Gotte Jun Chung

Author Response for "A Novel VEGFA Mutation As a Candidate for Causing Non‐syndromic Cleft Lip And/or Cleft Palate"

Functional Identification of a Rare Vascular Endothelial Growth Factor a (VEGFA) Variant Associating with the Nonsyndromic Cleft Lip With/without Cleft Palate

Author Response for "novel Bi‐allelic HPDL Variants Cause Hereditary Spastic Paraplegia in a Chinese Patient"

Author Response for "A Novel ENAM Mutation Causes Hypoplastic Amelogenesis Imperfect"

Author Response for "two Rare Variants Reveal the Significance of Grainyhead‐like 3 Arginine 391 Underlying Non‐syndromic Cleft Palate Only"

A novel IRF6 mutation causing non-syndromic cleft lip with or without cleft palate in a pedigree.

Genetic Analysis and Functional Assessment of a Variant in Micrognathia and Cleft Palate

Author ' s response to reviews Title : Argonaute proteins : potential biomarkers for human colon cancer

Cell Adhesion in Cancer

The Authors Reply:

Genome-Wide Analyses Identify A Novel Risk Locus For Nonsyndromic Cleft Palate

Author Response for "evidence of the Folate‐mediated One‐carbon Metabolism Pathway Genes in Controlling the Non‐syndromic Oral Clefts Risks"

A novel PTCH1 mutation underlies non-syndromic cleft lip and/or palate in a Han Chinese family.

A novel FZD6 mutation revealed the cause of cleft lip and/or palate in a Chinese family

Association of the 17-kDa extrinsic protein with photosystem II in higher plants.

Author Correction: Identification of Novel Genetic Variants Predisposing to Familial Oral Squamous Cell Carcinomas

The FGF and FGFR Gene Family and Risk of Cleft Lip with or Without Cleft Palate.

Research progress on non-syndromic cleft lip and/or palate in candidate genes

A novel splicing mutation of ARHGAP29 is associated with nonsyndromic cleft lip with or without cleft palate

Is MTHFD1 polymorphism rs 2236225 (c.1958G>A) associated with the susceptibility of NSCL/P? A systematic review and meta-analysis [version 2; referees: 2 approved]

Integrating GWAS and eQTL to predict genes and pathways for non-syndromic cleft lip with or without palate